Off-label marketing stirs a legal hornet's nest.
Guglielmo
Wayne J
WJ
D000588:Amines / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D011307:Drug Prescriptions; D000077206:Gabapentin; D006801:Humans; D016365:Liability, Legal; D040541:Marketing; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence*; D011356:Product Labeling; D014481:United States; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin